Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies (Q34198010)

31 July 2017

1 reference

title

Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies (English)

1 reference

31 July 2017

S MacMahon

1

1 reference

31 July 2017

R Collins

series ordinal

2

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

357

1 reference

31 July 2017

issue

9254

1 reference

31 July 2017

page(s)

455-462

1 reference

Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

The saga of thalidomide. Neuropathy to embryopathy, with case reports of congenital anomalies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Risk of Stevens-Johnson syndrome and toxic epider mal necrolysis during first weeks of antiepileptic therapy: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Hormone therapy to prevent disease and prolong life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Results of treatment in malignant hypertension: a seven-year experience in 94 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Observational evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Hormone replacement therapy, heart disease, and other considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Statins and the risk of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Underestimation of Risk Associations Due to Regression Dilution in Long-term Follow-up of Prospective Studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Aspirin use and chronic diseases: a cohort study of the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Reporting and Selection Bias in Case-Control Studies of Congenital Malformations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

A survey of childhood malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

On the use of affected controls to address recall bias in case-control studies of birth defects.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Reporting bias in retrospective ascertainment of drug-induced embryopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

The Risk of Myocardial Infarction Associated With Antihypertensive Drug Therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Principles of epidemiological research on drug effects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Principles of epidemiological research on drug effects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Association of road-traffic accidents with benzodiazepine use.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Estimating causal effects from large data sets using propensity scores

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Prior to use of estrogen replacement therapy, are users healthier than nonusers?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Postmenopausal estrogen and prevention bias

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Physical activity, obesity, and risk of colorectal adenoma in women (United States)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

A comparison of observational studies and randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Randomized, controlled trials, observational studies, and the hierarchy of research designs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Randomized trials or observational tribulations?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Digitalis-associated cardiac mortality after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

The effect of digoxin on mortality and morbidity in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Digoxin and mortality in chronic heart failure. UK Heart Investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Safety concerns about digoxin after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Why we need observational studies to evaluate the effectiveness of health care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Methods in health services research. Interpreting the evidence: choosing between randomised and non-randomised studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Reserpine use in relation to breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Calcium-channel blockade and incidence of cancer in aged populations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Can dietary beta-carotene materially reduce human cancer rates?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904017-4

7 January 2021

10.1016/S0140-6736(00)04017-4

Identifiers

DOI

1 reference

31 July 2017

1 reference